Clinicopathological characteristics and prognosis of stage IV colorectal cancer.

about

Function of the macrophage-capping protein in colorectal carcinoma.Novel prognostic prediction models for patients with stage IV colorectal cancer after concurrent curative resection.

P2860

Q45404472-52603A9B-7330-42E7-ACB5-E2F796844DDA Q54863313-E7A38BE8-9F2E-459D-AA02-13563A8C8293

P2860

Clinicopathological characteristics and prognosis of stage IV colorectal cancer.

Item

http://www.wikidata.org/entity/Q41865458

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Clinicopathological characteristics and prognosis of stage IV colorectal cancer.

@en

type

Item

label

Clinicopathological characteristics and prognosis of stage IV colorectal cancer.

@en

prefLabel

Clinicopathological characteristics and prognosis of stage IV colorectal cancer.

@en

P1476

Clinicopathological characteristics and prognosis of stage IV colorectal cancer.

@en

P2093

Hidenori Takahashi

http://www.w3.org/2001/XMLSchema#string

Hirofumi Akita

http://www.w3.org/2001/XMLSchema#string

Jiro Okami

http://www.w3.org/2001/XMLSchema#string

Keijiro Sugimura

http://www.w3.org/2001/XMLSchema#string

Kentaro Kishi

http://www.w3.org/2001/XMLSchema#string

Kunihito Gotoh

http://www.w3.org/2001/XMLSchema#string

Masaaki Motoori

http://www.w3.org/2001/XMLSchema#string

Masahiko Higashiyama

http://www.w3.org/2001/XMLSchema#string

Masahiko Yano

http://www.w3.org/2001/XMLSchema#string

Masayuki Ohue

http://www.w3.org/2001/XMLSchema#string

P2860

Phase II study of neoadjuvant 5-FU + leucovorin + CPT-11 in patients with resectable liver metastases from colorectal adenocarcinoma

Cancer statistics, 2010

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

Panitumumab versus cetuximab in patients with chemotherapy-refractory wild-type KRAS exon 2 metastatic colorectal cancer (ASPECCT): a randomised, multicentre, open-label, non-inferiority phase 3 study

PEAK: a randomized, multicenter phase II study of panitumumab plus modified fluorouracil, leucovorin, and oxaliplatin (mFOLFOX6) or bevacizumab plus mFOLFOX6 in patients with previously untreated, unresectable, wild-type KRAS exon 2 metastatic color

The beneficial effect of palliative resection in metastatic colorectal cancer.

Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2010 for the treatment of colorectal cancer.

Abnormal expression of TRIB3 in colorectal cancer: a novel marker for prognosis.

Prognostic factors influencing the survival of patients with colon cancer receiving adjuvant 5-FU treatment.

Survival of patients with advanced colorectal cancer improves with the availability of fluorouracil-leucovorin, irinotecan, and oxaliplatin in the course of treatment.

P304

1093-1098

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/MCO.2015.598

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-07-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

279025498

http://www.w3.org/2001/XMLSchema#string

P698

26623057

http://www.w3.org/2001/XMLSchema#string

P921

colorectal cancer

P932

4534880

http://www.w3.org/2001/XMLSchema#string

Clinicopathological characteristics and prognosis of stage IV colorectal cancer.

about

P2860

P2860

Clinicopathological characteristics and prognosis of stage IV colorectal cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P932